Novo Nordisk Inks $1.1B Deal For German Pharma Biz

By Josh White · March 25, 2024, 5:56 PM GMT

Danish pharmaceutical giant Novo Nordisk A/S said Monday it has signed a deal to acquire Cardior Pharmaceuticals of Germany for just over €1 billion ($1.1 billion) to widen its focus on...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

This Week's Healthcare Earnings: UnitedHealth, AstraZeneca No Photo Available

Yeji Jesse Lee

A host of companies posted their second-quarter financial results this past week, offering a look into how health systems, payors and ... (more story)

9th Circ. Clarifies Kickback Boundaries For Referral Bonuses No Photo Available

Dan McKay

A Ninth Circuit opinion affirming a California man's fraud conviction provides some clarity — and a warning — to the owners of medical... (more story)

Stanford Health Atty Talks AI Ethics In Patient Care No Photo Available

Yeji Jesse Lee

As hospitals embrace artificial intelligence as part of patient care, they're asking an important question: When and how should patients be told?